GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

The $1 billion plant will manufacture the HPV vaccines Gardasil and Gardasil 9, while the site continues to produce vaccines against measles, mumps, rubella, and chickenpox, among other illnesses ...

A steep fall in demand from China drove a 41% decline in MSD Q1 2025 sales of its human papillomavirus (HPV) vaccines Gardasil and Gardasil 9, marking a continued setback for the company’s ...

Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks.

United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...

Merck (MRK) stock trades flat as the company lowers earnings outlook amid tariff impact, even as its Q1 2025 results beat ...

vaccine franchise, Gardasil/Gardasil 9 continued to underperform. While Merck’s (NYSE:MRK) cancer blockbuster Keytruda generated $7.2B in sales with ~4% YoY growth, GARDASIL/GARDASIL 9 sales ...

The vaccine, known as Gardasil, has been given to millions of ... Currently, CDC recommendations already suggest adolescents aged 9 to 14 get two doses. Three doses are recommended for teens ...

Merck said today its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, reflecting a ...

The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.